Candel Therapeutics (CADL) Revenue: 2020-2023
Historic Revenue for Candel Therapeutics (CADL) over the last 4 years, with Dec 2023 value amounting to $4.5 million.
- Candel Therapeutics' Revenue rose 14470.97% to $4.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.6 million, marking a year-over-year increase of 1992.74%. This contributed to the annual value of $2.1 million for FY2024, which is 19.46% down from last year.
- Per Candel Therapeutics' latest filing, its Revenue stood at $4.5 million for Q4 2023, which was up 775.19% from -$669,000 recorded in Q3 2023.
- Candel Therapeutics' 5-year Revenue high stood at $4.5 million for Q4 2023, and its period low was -$669,000 during Q3 2023.
- Its 3-year average for Revenue is $236,917, with a median of $31,000 in 2022.
- Examining YoY changes over the last 5 years, Candel Therapeutics' Revenue showed a top increase of 14,470.97% in 2023 and a maximum decrease of 2,258.06% in 2023.
- Over the past 4 years, Candel Therapeutics' Revenue (Quarterly) stood at $31,000 in 2020, then remained steady at $31,000 in 2021, then remained steady at $31,000 in 2022, then surged by 14,470.97% to $4.5 million in 2023.
- Its Revenue stands at $4.5 million for Q4 2023, versus -$669,000 for Q3 2023 and -$644,000 for Q2 2023.